JEROME MARCOS: Open Payments
NPI 1538462999 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 6 payments from 6 companies in 2025. Trend: 2023 $1,744 · 2024 $0 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| GENZYME CORPORATION | 1 | $111 |
| Abbott Laboratories | 1 | $71 |
| Globus Medical, Inc. | 1 | $50 |
Products named: OJJAARA, BREYANZI, AUSTEDO XR, INFINITY, Senza.
Industry payments across CA — which companies pay providers there.
